According to CenterWatch analysis, the medical writing market has more than doubled in size during the past five years, increasing from an estimated $345 million in 2003 to $694 million in 2008.
Making the Business Case for Accreditation
When the Association for the Accreditation of Human Research Protection Programs (AAHRPP) launched in 2001, its first accredited organizations comprised a few market segments. Today, AAHRPP has accredited 138 parent organizations, representing more than 600 entities from almost every type of human research organization.
Conditional and Accelerated Approach No Easy Route to Market Success
The accelerated and conditional approval processes are coming under close scrutiny in Europe, raising the possibility of a shake-up in how priority drugs are regulated over the coming months. One casualty could be the randomized clinical trial’s position as the “gold standard” of evidence in assessing drug efficacy.
Eye On: Juvenile Arthritis
Juvenile arthritis (JA), which is any type of arthritis or arthritis-related condition in young people under 18 years of age, affects approximately 294,000 children in the United States, according to the Arthritis Foundation. Typical symptoms are joint pain, swelling, tenderness and stiffness, which must be confirmed by physical examination. Ultimately, JA may progress to cause restricted range of motion, contracture, damage, deformity and/or altered growth of affected joints.
To read the full articles for this issue or for more information on these and other breaking stories, pleaseclick here
